Point of Care Molecular Diagnostics Market revenue to cross USD 4.8 Bn by 2027: Global Market Insights Inc.


You May Also Like

Novartis’ Xolair® recommended in new global chronic urticaria guideline

Xolair® (omalizumab), indicated as add-on therapy for the treatment of chronic spontaneous urticaria (CSU)[1], ...

American Gene Technologies Gains Additional Immuno-Oncology Patent

ROCKVILLE, Md., March 19, 2018 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (AGT), ...